{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "18",
                "@year": "2021",
                "@timestamp": "2021-09-18T17:57:32.000032-04:00",
                "@month": "09"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2020",
                "@month": "11"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": [
                {
                    "xocs:funding-agency-matched-string": "Ministry of Public Health",
                    "xocs:funding-agency-acronym": "MOPH",
                    "xocs:funding-agency": "Ministry of Public Health",
                    "xocs:funding-id": [
                        {"$": "119/2562"},
                        {"$": "249/2562"}
                    ],
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100004397",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
                },
                {
                    "xocs:funding-agency-matched-string": "Faculty of Medicine, Chulalongkorn University",
                    "xocs:funding-agency-acronym": "MDCU",
                    "xocs:funding-agency": "Faculty of Medicine, Chulalongkorn University",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100004776",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
                },
                {
                    "xocs:funding-agency-matched-string": "Faculty of Medicine Siriraj Hospital, Mahidol University",
                    "xocs:funding-agency": "Faculty of Medicine Siriraj Hospital, Mahidol University",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100013238",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
                }
            ],
            "xocs:funding-addon-generated-timestamp": "2021-06-05T03:40:32.656Z",
            "xocs:funding-text": [
                {"$": "The authors thank Thai FDA, Ministry of Public Health, Thailand for providing the opportunity and financial support for this work. The authors thank Faculty of Medicine Siriraj Hospital, Mahidol University and Faculty of Medicine, Chulalongkorn University for the data and Natchamol Tophol, research assistant, for collecting the data."},
                {"$": "This work was supported by Thai Food and Drug Administration (Thai FDA), Ministry of Public Health to support National List of Essential Medicine Selection Process of Thailand [grant numbers 119/2562 and 249/2562]."}
            ],
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60011189",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of Ambulatory Medicine"},
                                {"$": "Department of Medicine"},
                                {"$": "Faculty of Medicine Siriraj Hospital"},
                                {"$": "Mahidol University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60011189",
                                    "@dptid": "100276929"
                                },
                                {"@afid": "60012718"}
                            ],
                            "@affiliation-instance-id": "2005857903-c0b09944fd6d58a97cc18c467a5125c5",
                            "ce:source-text": "Division of Ambulatory Medicine, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand",
                            "@dptid": "100276929"
                        },
                        "author": [
                            {
                                "ce:given-name": "Pochamana",
                                "preferred-name": {
                                    "ce:given-name": "Pochamana",
                                    "ce:initials": "P.",
                                    "ce:surname": "Phisalprapa",
                                    "ce:indexed-name": "Phisalprapa P."
                                },
                                "@seq": "1",
                                "@author-instance-id": "2005857903-2aa504e61c109972c11b1bebc778d7c5",
                                "ce:initials": "P.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Phisalprapa",
                                "@auid": "54419010300",
                                "@orcid": "0000-0003-1995-4405",
                                "ce:indexed-name": "Phisalprapa P."
                            },
                            {
                                "ce:given-name": "Chayanis",
                                "preferred-name": {
                                    "ce:given-name": "Chayanis",
                                    "ce:initials": "C.",
                                    "ce:surname": "Kositamongkol",
                                    "ce:indexed-name": "Kositamongkol C."
                                },
                                "@seq": "2",
                                "@author-instance-id": "2005857903-8441526bc7d75460feeaf616a8011b6e",
                                "ce:initials": "C.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Kositamongkol",
                                "@auid": "57218533231",
                                "@orcid": "0000-0001-7182-0733",
                                "ce:indexed-name": "Kositamongkol C."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60011189",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of Gastroenterology"},
                                {"$": "Department of Medicine"},
                                {"$": "Faculty of Medicine Siriraj Hospital"},
                                {"$": "Mahidol University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60011189",
                                    "@dptid": "100276929"
                                },
                                {"@afid": "60012718"}
                            ],
                            "@affiliation-instance-id": "2005857903-d6d5d9bc58902ca412d69e231d0866db",
                            "ce:source-text": "Division of Gastroenterology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand",
                            "@dptid": "100276929"
                        },
                        "author": [
                            {
                                "ce:given-name": "Julajak",
                                "preferred-name": {
                                    "ce:given-name": "Julajak",
                                    "ce:initials": "J.",
                                    "ce:surname": "Limsrivilai",
                                    "ce:indexed-name": "Limsrivilai J."
                                },
                                "@seq": "3",
                                "@author-instance-id": "2005857903-236c1982e0fcbb2909b6e84fc0356fdb",
                                "ce:initials": "J.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Limsrivilai",
                                "@auid": "12772292800",
                                "@orcid": "0000-0001-5867-0312",
                                "ce:indexed-name": "Limsrivilai J."
                            },
                            {
                                "ce:given-name": "Phunchai",
                                "preferred-name": {
                                    "ce:given-name": "Phunchai",
                                    "ce:initials": "P.",
                                    "ce:surname": "Charatcharoenwitthaya",
                                    "ce:indexed-name": "Charatcharoenwitthaya P."
                                },
                                "@seq": "5",
                                "@author-instance-id": "2005857903-1a41500e158c6ca4e2cfac2ac904ba56",
                                "ce:initials": "P.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Charatcharoenwitthaya",
                                "@auid": "12778111900",
                                "@orcid": "0000-0002-8334-0267",
                                "ce:indexed-name": "Charatcharoenwitthaya P."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Gastroenterology Unit"},
                                {"$": "Department of Internal Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "107887048"
                            },
                            "@affiliation-instance-id": "2005857903-d996242c5e101df7d56ea79d4bf99f96",
                            "ce:source-text": "Gastroenterology Unit, Department of Internal Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "107887048"
                        },
                        "author": [{
                            "ce:given-name": "Satimai",
                            "preferred-name": {
                                "ce:given-name": "Satimai",
                                "ce:initials": "S.",
                                "ce:surname": "Aniwan",
                                "ce:indexed-name": "Aniwan S."
                            },
                            "@seq": "4",
                            "@author-instance-id": "2005857903-4a2e220544c6041d958856c342bc511a",
                            "ce:initials": "S.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Aniwan",
                            "@auid": "36010544000",
                            "@orcid": "0000-0002-2730-2450",
                            "ce:indexed-name": "Aniwan S."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60020543",
                            "@country": "tha",
                            "organization": [
                                {"$": "Digestive Disease Center"},
                                {"$": "Bumrungrad International Hospital"}
                            ],
                            "affiliation-id": {
                                "@afid": "60020543",
                                "@dptid": "115841080"
                            },
                            "@affiliation-instance-id": "2005857903-246fd3c8d8d103d71178b8380687ac17",
                            "ce:source-text": "Digestive Disease Center, Bumrungrad International Hospital",
                            "@dptid": "115841080"
                        },
                        "author": [{
                            "ce:given-name": "Pises",
                            "preferred-name": {
                                "ce:given-name": "Pises",
                                "ce:initials": "P.",
                                "ce:surname": "Pisespongsa",
                                "ce:indexed-name": "Pisespongsa P."
                            },
                            "@seq": "6",
                            "@author-instance-id": "2005857903-b3ab34d4d6eb2a76fe303bff88d9ae78",
                            "ce:initials": "P.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Pisespongsa",
                            "@auid": "15846592300",
                            "@orcid": "0000-0002-3181-546X",
                            "ce:indexed-name": "Pisespongsa P."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60199578",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of Gastroenterology and Hepatology"},
                                {"$": "Department of Medicine"},
                                {"$": "Ramathibodi Hospital"},
                                {"$": "Mahidol University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60199578",
                                    "@dptid": "125763061"
                                },
                                {"@afid": "60012718"}
                            ],
                            "@affiliation-instance-id": "2005857903-c5ab48be68794469213de041189f143f",
                            "ce:source-text": "Division of Gastroenterology and Hepatology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand",
                            "@dptid": "125763061"
                        },
                        "author": [{
                            "ce:given-name": "Taya",
                            "preferred-name": {
                                "ce:given-name": "Taya",
                                "ce:initials": "T.",
                                "ce:surname": "Kitiyakara",
                                "ce:indexed-name": "Kitiyakara T."
                            },
                            "@seq": "7",
                            "@author-instance-id": "2005857903-5d8de188ba779e3ea4939cb9b6cdf59c",
                            "ce:initials": "T.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Kitiyakara",
                            "@auid": "8275586600",
                            "@orcid": "0000-0002-7938-1752",
                            "ce:indexed-name": "Kitiyakara T."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60015887",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Department of Pediatrics"},
                                {"$": "Faculty of Medicine Ramathibodi Hospital"},
                                {"$": "Mahidol University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60015887",
                                    "@dptid": "112998834"
                                },
                                {"@afid": "60012718"}
                            ],
                            "@affiliation-instance-id": "2005857903-08e12a8856b800a8badfea3563b3bfbe",
                            "ce:source-text": "Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand",
                            "@dptid": "112998834"
                        },
                        "author": [{
                            "ce:given-name": "Suporn",
                            "preferred-name": {
                                "ce:given-name": "Suporn",
                                "ce:initials": "S.",
                                "ce:surname": "Treepongkaruna",
                                "ce:indexed-name": "Treepongkaruna S."
                            },
                            "@seq": "8",
                            "@author-instance-id": "2005857903-348b2e012e806cb9af6539899bea3e0b",
                            "ce:initials": "S.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Treepongkaruna",
                            "@auid": "57195461878",
                            "@orcid": "0000-0002-6651-2282",
                            "ce:indexed-name": "Treepongkaruna S."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60025488",
                            "@country": "usa",
                            "city": "Salt Lake City",
                            "organization": [
                                {"$": "College of Pharmacy"},
                                {"$": "University of Utah"}
                            ],
                            "affiliation-id": {
                                "@afid": "60025488",
                                "@dptid": "113248074"
                            },
                            "state": "UT",
                            "@affiliation-instance-id": "2005857903-3262d6809d81de77686b631db6c96c36",
                            "ce:source-text": "College of Pharmacy, University of Utah, Salt Lake City, UT, USA",
                            "@dptid": "113248074"
                        },
                        "author": [{
                            "ce:given-name": "Nathorn",
                            "preferred-name": {
                                "ce:given-name": "Nathorn",
                                "ce:initials": "N.",
                                "ce:surname": "Chaiyakunapruk",
                                "ce:indexed-name": "Chaiyakunapruk N."
                            },
                            "@seq": "9",
                            "@author-instance-id": "2005857903-64dac3edca92190a33b87157eb9803f8",
                            "ce:initials": "N.",
                            "@date-locked": "2020-09-07T09:50:45.493",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Chaiyakunapruk",
                            "@auid": "14015058100",
                            "@orcid": "0000-0003-4572-8794",
                            "ce:indexed-name": "Chaiyakunapruk N."
                        }]
                    }
                ],
                "citation-title": "Cost-effectiveness and budget impact analysis of infliximab and its biosimilar in patients with refractory moderate-to-severe Crohn\u2019s disease using real world evidence in Thailand",
                "abstracts": "Â© 2020 Informa UK Limited, trading as Taylor & Francis Group.Aims: This study aimed to conduct a cost-effectiveness analysis of infliximab and its biosimilar compared to conventional therapy in refractory moderate-to-severe Crohn\u2019s disease (CD) in Thailand. Materials and methods: A Markov model was used to estimate lifetime costs and health benefits of infliximab from a societal perspective. Our analyses consisted of three choices of treatment (conventional therapy, infliximab originator, and biosimilar) and three treatment scenarios (infliximab 2 years and 3 years if relapse, infliximab 2 years and lifelong if relapse, and infliximab lifelong). The input parameters were obtained from the CD registry and systematic literature reviews. The results were reported as incremental cost-effectiveness ratios (ICERs) in 2017 USD per quality-adjusted life year (QALY) gained. The sensitivity analyses were performed to assess the influence of parameter uncertainty. Threshold sensitivity analyses were carried out to determine the optimal drug prices. Finally, budget impact analyses were conducted. Results: None of the scenarios was cost-effective at Thai willingness-to-pay threshold (4,706 USD/QALY gained). The lowest ICER of 30,121 USD/QALY gained was reported in the scenario that included only standard dose of infliximab biosimilar with the maximum of 5-year treatment. The drug prices need to be reduced by at least 72% to allow infliximab biosimilar to be cost-effective. The 5-year budget impact was only 695,958 USD for the current biosimilar price. Conclusions: Infliximab for the treatment of refractory moderate-to-severe CD in Thailand would be cost-effective if the drug prices were significantly decreased. The best value for money strategy was infliximab biosimilar with a restricted duration of treatment.Key points The use of infliximab and its biosimilar in a restricted duration of maximum 5-year is not cost-effective for patients with moderate-to-severe Crohn\u2019s disease refractory to conventional therapy, unless their price was lowered around 72\u201390% in Thailand. The estimated budget impact for adopting infliximab or its biosimilar for such indication has potential financial feasibility. Policy makers may consider cost-effectiveness and budget impact findings as well as other aspects such as rarity of disease as a part of the decision making process.",
                "correspondence": {
                    "affiliation": {
                        "country": "United States",
                        "postal-code": "84112",
                        "@country": "usa",
                        "city": "Salt Lake City",
                        "organization": [
                            {"$": "Department of Pharmacotherapy"},
                            {"$": "College of Pharmacy"},
                            {"$": "University of Utah"}
                        ],
                        "state": "UT",
                        "ce:source-text": "Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT, 84112, USA"
                    },
                    "person": {
                        "ce:given-name": "Nathorn",
                        "ce:initials": "N.",
                        "ce:surname": "Chaiyakunapruk",
                        "ce:indexed-name": "Chaiyakunapruk N."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "biosimilar",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Cost-effectiveness analysis",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Crohn's disease",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "infliximab",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Thailand",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "http://www.tandfonline.com/loi/ijme20",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "Journal of Medical Economics",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {
                        "voliss": {
                            "@volume": "23",
                            "@issue": "11"
                        },
                        "pagerange": {
                            "@first": "1302",
                            "@last": "1310"
                        }
                    },
                    "@type": "j",
                    "sourcetitle": "Journal of Medical Economics",
                    "publicationdate": {
                        "month": "11",
                        "year": "2020",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "1 November 2020"
                        },
                        "day": "01"
                    },
                    "codencode": "JMECF",
                    "sourcetitle-abbrev": "J. Med. Econ.",
                    "@country": "gbr",
                    "issn": [
                        {
                            "$": "1941837X",
                            "@type": "electronic"
                        },
                        {
                            "$": "13696998",
                            "@type": "print"
                        }
                    ],
                    "publicationyear": {"@first": "2020"},
                    "publisher": {"publishername": "Taylor and Francis Ltd."},
                    "@srcid": "15951"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "36",
                                    "classification-description": "Health Policy, Economics and Management"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "48",
                                    "classification-description": "Gastroenterology"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": "2719"
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": "MEDI"
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": {
                                "cas-registry-number": "170277-31-3",
                                "chemical-name": "infliximab"
                            }
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "Biosimilar Pharmaceuticals"},
                                {"chemical-name": "Infliximab"}
                            ]
                        }
                    ]}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "The authors thank Thai FDA, Ministry of Public Health, Thailand for providing the opportunity and financial support for this work. The authors thank Faculty of Medicine Siriraj Hospital, Mahidol University and Faculty of Medicine, Chulalongkorn University for the data and Natchamol Tophol, research assistant, for collecting the data.",
                        "@xml:lang": "eng"
                    }
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2020 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "In-Process",
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "NURSNG"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "16",
                    "@year": "2020",
                    "@timestamp": "BST 03:42:00",
                    "@month": "12"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2005857903",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "632487151",
                            "@idtype": "associatedPUI"
                        },
                        {
                            "$": "927805718",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20200684985",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "32729347",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "2020316012",
                            "@idtype": "NURSNG"
                        },
                        {
                            "$": "20201777799",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20202960636",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "20200012990252",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85089453513",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85089453513",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "632487151",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "77061099",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:doi": "10.1080/13696998.2020.1803889"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "44",
                "reference": [
                    {
                        "ref-fulltext": "Buxton MJ, Lacey LA, Feagan BG, et al. Mapping from disease-specific measures to utility: an analysis of the relationships between the Inflammatory Bowel Disease Questionnaire and Crohn\u2019s Disease Activity Index in Crohn\u2019s disease and measures of utility. Value Health. 2007; 10: 214\u2013220.",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Mapping from disease-specific measures to utility: an analysis of the relationships between the Inflammatory Bowel Disease Questionnaire and Crohn\u2019s Disease Activity Index in Crohn\u2019s disease and measures of utility"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "34249026625",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "10"},
                                "pagerange": {
                                    "@first": "214",
                                    "@last": "220"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Buxton",
                                        "ce:indexed-name": "Buxton M.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Lacey",
                                        "ce:indexed-name": "Lacey L.A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Feagan",
                                        "ce:indexed-name": "Feagan B.G."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Value Health"
                        },
                        "ce:source-text": "Buxton MJ, Lacey LA, Feagan BG, et al. Mapping from disease-specific measures to utility: an analysis of the relationships between the Inflammatory Bowel Disease Questionnaire and Crohn\u2019s Disease Activity Index in Crohn\u2019s disease and measures of utility. Value Health. 2007; 10: 214\u2013220."
                    },
                    {
                        "ref-fulltext": "Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. The Lancet. 2017; 390: 2769\u20132778.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0002",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85031499214",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "390"},
                                "pagerange": {
                                    "@first": "2769",
                                    "@last": "2778"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Ng",
                                        "ce:indexed-name": "Ng S.C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Shi",
                                        "ce:indexed-name": "Shi H.Y."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Hamidi",
                                        "ce:indexed-name": "Hamidi N."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "The Lancet"
                        },
                        "ce:source-text": "Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. The Lancet. 2017; 390: 2769\u20132778."
                    },
                    {
                        "ref-fulltext": "Ng SC, Tang W, Ching JY, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn\u2019s and colitis epidemiology study. Gastroenterology. 2013; 145: 158\u2013165 e2.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn\u2019s and colitis epidemiology study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0003",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84879479335",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "145"},
                                "pagerange": {
                                    "@first": "158",
                                    "@last": "165 e2"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Ng",
                                        "ce:indexed-name": "Ng S.C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "W.",
                                        "@_fa": "true",
                                        "ce:surname": "Tang",
                                        "ce:indexed-name": "Tang W."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Ching",
                                        "ce:indexed-name": "Ching J.Y."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "Ng SC, Tang W, Ching JY, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn\u2019s and colitis epidemiology study. Gastroenterology. 2013; 145: 158\u2013165 e2."
                    },
                    {
                        "ref-fulltext": "Behzadi P, Behzadi E, Ranjbar R., The incidence and prevalence of Crohn\u2019s disease in global scale. SOJI. 2015; 3.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "The incidence and prevalence of Crohn\u2019s disease in global scale"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0004",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84962716139",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "3"}},
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Behzadi",
                                    "ce:indexed-name": "Behzadi P."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Behzadi",
                                    "ce:indexed-name": "Behzadi E."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Ranjbar",
                                    "ce:indexed-name": "Ranjbar R."
                                }
                            ]},
                            "ref-sourcetitle": "SOJI"
                        },
                        "ce:source-text": "Behzadi P, Behzadi E, Ranjbar R., The incidence and prevalence of Crohn\u2019s disease in global scale. SOJI. 2015; 3."
                    },
                    {
                        "ref-fulltext": "Ng SC, Kaplan GG, Tang W, et al. Population density and risk of inflammatory bowel disease: a prospective population-based study in 13 countries or regions in Asia-Pacific. Am J Gastroenterol. 2019; 114: 107\u2013115.",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Population density and risk of inflammatory bowel disease: a prospective population-based study in 13 countries or regions in Asia-Pacific"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0005",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85053307043",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "114"},
                                "pagerange": {
                                    "@first": "107",
                                    "@last": "115"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Ng",
                                        "ce:indexed-name": "Ng S.C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Kaplan",
                                        "ce:indexed-name": "Kaplan G.G."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "W.",
                                        "@_fa": "true",
                                        "ce:surname": "Tang",
                                        "ce:indexed-name": "Tang W."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Am J Gastroenterol"
                        },
                        "ce:source-text": "Ng SC, Kaplan GG, Tang W, et al. Population density and risk of inflammatory bowel disease: a prospective population-based study in 13 countries or regions in Asia-Pacific. Am J Gastroenterol. 2019; 114: 107\u2013115."
                    },
                    {
                        "ref-fulltext": "Bewtra M, Kaiser LM, TenHave T, et al. Crohn\u2019s disease and ulcerative colitis are associated with elevated standardized mortality ratios: a meta-analysis. Inflamm Bowel Dis. 2013; 19: 599\u2013613.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Crohn\u2019s disease and ulcerative colitis are associated with elevated standardized mortality ratios: a meta-analysis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0006",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84876390568",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "19"},
                                "pagerange": {
                                    "@first": "599",
                                    "@last": "613"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Bewtra",
                                        "ce:indexed-name": "Bewtra M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Kaiser",
                                        "ce:indexed-name": "Kaiser L.M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "TenHave",
                                        "ce:indexed-name": "TenHave T."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Inflamm Bowel Dis"
                        },
                        "ce:source-text": "Bewtra M, Kaiser LM, TenHave T, et al. Crohn\u2019s disease and ulcerative colitis are associated with elevated standardized mortality ratios: a meta-analysis. Inflamm Bowel Dis. 2013; 19: 599\u2013613."
                    },
                    {
                        "ref-fulltext": "Stidham RW, Lee TC, Higgins PD, et al. Systematic review with network meta-analysis: the efficacy of anti-TNF agents for the treatment of Crohn\u2019s disease. Aliment Pharmacol Ther. 2014; 39: 1349\u20131362.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Systematic review with network meta-analysis: the efficacy of anti-TNF agents for the treatment of Crohn\u2019s disease"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0007",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84901497185",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "39"},
                                "pagerange": {
                                    "@first": "1349",
                                    "@last": "1362"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Stidham",
                                        "ce:indexed-name": "Stidham R.W."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Lee",
                                        "ce:indexed-name": "Lee T.C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.D.",
                                        "@_fa": "true",
                                        "ce:surname": "Higgins",
                                        "ce:indexed-name": "Higgins P.D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Aliment Pharmacol Ther"
                        },
                        "ce:source-text": "Stidham RW, Lee TC, Higgins PD, et al. Systematic review with network meta-analysis: the efficacy of anti-TNF agents for the treatment of Crohn\u2019s disease. Aliment Pharmacol Ther. 2014; 39: 1349\u20131362."
                    },
                    {
                        "ref-fulltext": "Fumery M, Dulai PS, Meirick P, et al. Systematic review with meta-analysis: recurrence of Crohn\u2019s disease after total colectomy with permanent ileostomy. Aliment Pharmacol Ther. 2017; 45: 381\u2013390.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Systematic review with meta-analysis: recurrence of Crohn\u2019s disease after total colectomy with permanent ileostomy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0008",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85006488946",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "45"},
                                "pagerange": {
                                    "@first": "381",
                                    "@last": "390"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Fumery",
                                        "ce:indexed-name": "Fumery M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Dulai",
                                        "ce:indexed-name": "Dulai P.S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Meirick",
                                        "ce:indexed-name": "Meirick P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Aliment Pharmacol Ther"
                        },
                        "ce:source-text": "Fumery M, Dulai PS, Meirick P, et al. Systematic review with meta-analysis: recurrence of Crohn\u2019s disease after total colectomy with permanent ileostomy. Aliment Pharmacol Ther. 2017; 45: 381\u2013390."
                    },
                    {
                        "ref-fulltext": "Lichtenstein GR, Loftus EV, Isaacs KL, et al. ACG clinical guideline: management of Crohn\u2019s disease in adults. Am J Gastroenterol. 2018; 113: 481\u2013517.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "ACG clinical guideline: management of Crohn\u2019s disease in adults"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0009",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85044836612",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "113"},
                                "pagerange": {
                                    "@first": "481",
                                    "@last": "517"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "G.R.",
                                        "@_fa": "true",
                                        "ce:surname": "Lichtenstein",
                                        "ce:indexed-name": "Lichtenstein G.R."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.V.",
                                        "@_fa": "true",
                                        "ce:surname": "Loftus",
                                        "ce:indexed-name": "Loftus E.V."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Isaacs",
                                        "ce:indexed-name": "Isaacs K.L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Am J Gastroenterol"
                        },
                        "ce:source-text": "Lichtenstein GR, Loftus EV, Isaacs KL, et al. ACG clinical guideline: management of Crohn\u2019s disease in adults. Am J Gastroenterol. 2018; 113: 481\u2013517."
                    },
                    {
                        "ref-fulltext": "Lamb CA, Kennedy NA, Raine T, et al.; IBD guidelines eDelphi consensus group. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019; 68: s1\u2013s106.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0010",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85070056729",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "68"},
                                "pagerange": {
                                    "@first": "s1",
                                    "@last": "s106"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Lamb",
                                        "ce:indexed-name": "Lamb C.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "N.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Kennedy",
                                        "ce:indexed-name": "Kennedy N.A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Raine",
                                        "ce:indexed-name": "Raine T."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gut"
                        },
                        "ce:source-text": "Lamb CA, Kennedy NA, Raine T, et al.; IBD guidelines eDelphi consensus group. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019; 68: s1\u2013s106."
                    },
                    {
                        "ref-fulltext": "Gomollon F, Dignass A, Annese V, ECCO, et al. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn\u2019s Disease 2016: part 1: diagnosis and medical management. J Crohns Colitis. 2017; 11: 3\u201325.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn\u2019s Disease 2016: part 1: diagnosis and medical management"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0011",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85016186433",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "11"},
                                "pagerange": {
                                    "@first": "3",
                                    "@last": "25"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "F.",
                                    "@_fa": "true",
                                    "ce:surname": "Gomollon",
                                    "ce:indexed-name": "Gomollon F."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Dignass",
                                    "ce:indexed-name": "Dignass A."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "V.",
                                    "@_fa": "true",
                                    "ce:surname": "Annese",
                                    "ce:indexed-name": "Annese V."
                                }
                            ]},
                            "ref-sourcetitle": "J Crohns Colitis"
                        },
                        "ce:source-text": "Gomollon F, Dignass A, Annese V, ECCO, et al. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn\u2019s Disease 2016: part 1: diagnosis and medical management. J Crohns Colitis. 2017; 11: 3\u201325."
                    },
                    {
                        "ref-fulltext": "Meyer A, Rudant J, Drouin J, et al. Effectiveness and safety of reference infliximab and biosimilar in Crohn disease: a French equivalence study. Ann Intern Med. 2019; 170: 99\u2013107.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Effectiveness and safety of reference infliximab and biosimilar in Crohn disease: a French equivalence study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0012",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85059989736",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "170"},
                                "pagerange": {
                                    "@first": "99",
                                    "@last": "107"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Meyer",
                                        "ce:indexed-name": "Meyer A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Rudant",
                                        "ce:indexed-name": "Rudant J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Drouin",
                                        "ce:indexed-name": "Drouin J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Intern Med"
                        },
                        "ce:source-text": "Meyer A, Rudant J, Drouin J, et al. Effectiveness and safety of reference infliximab and biosimilar in Crohn disease: a French equivalence study. Ann Intern Med. 2019; 170: 99\u2013107."
                    },
                    {
                        "ref-fulltext": "Marchetti M, Liberato NL., Biological therapies in Crohn\u2019s disease: are they cost-effective? A critical appraisal of model-based analyses. Expert Rev Pharmacoecon Outcomes Res. 2014; 14: 815\u2013824.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Biological therapies in Crohn\u2019s disease: are they cost-effective? A critical appraisal of model-based analyses"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0013",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84909981446",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "14"},
                                "pagerange": {
                                    "@first": "815",
                                    "@last": "824"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Marchetti",
                                    "ce:indexed-name": "Marchetti M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "N.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Liberato",
                                    "ce:indexed-name": "Liberato N.L."
                                }
                            ]},
                            "ref-sourcetitle": "Expert Rev Pharmacoecon Outcomes Res"
                        },
                        "ce:source-text": "Marchetti M, Liberato NL., Biological therapies in Crohn\u2019s disease: are they cost-effective? A critical appraisal of model-based analyses. Expert Rev Pharmacoecon Outcomes Res. 2014; 14: 815\u2013824."
                    },
                    {
                        "ref-fulltext": "Pillai N, Dusheiko M, Burnand B, et al. A systematic review of cost-effectiveness studies comparing conventional, biological and surgical interventions for inflammatory bowel disease. PLoS One. 2017; 12: e0185500.",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "A systematic review of cost-effectiveness studies comparing conventional, biological and surgical interventions for inflammatory bowel disease"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0014",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "e0185500",
                                    "@idtype": "ARTNUM"
                                },
                                {
                                    "$": "85030456231",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "12"}},
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Pillai",
                                        "ce:indexed-name": "Pillai N."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Dusheiko",
                                        "ce:indexed-name": "Dusheiko M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Burnand",
                                        "ce:indexed-name": "Burnand B."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "PLoS One"
                        },
                        "ce:source-text": "Pillai N, Dusheiko M, Burnand B, et al. A systematic review of cost-effectiveness studies comparing conventional, biological and surgical interventions for inflammatory bowel disease. PLoS One. 2017; 12: e0185500."
                    },
                    {
                        "ref-fulltext": "Smart C, Selinger CP., The cost-effectiveness of infliximab in Crohn\u2019s disease. Expert Rev Pharmacoecon Outcomes Res. 2014; 14: 589\u2013598.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "The cost-effectiveness of infliximab in Crohn\u2019s disease"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0015",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84907063017",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "14"},
                                "pagerange": {
                                    "@first": "589",
                                    "@last": "598"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Smart",
                                    "ce:indexed-name": "Smart C."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "C.P.",
                                    "@_fa": "true",
                                    "ce:surname": "Selinger",
                                    "ce:indexed-name": "Selinger C.P."
                                }
                            ]},
                            "ref-sourcetitle": "Expert Rev Pharmacoecon Outcomes Res"
                        },
                        "ce:source-text": "Smart C, Selinger CP., The cost-effectiveness of infliximab in Crohn\u2019s disease. Expert Rev Pharmacoecon Outcomes Res. 2014; 14: 589\u2013598."
                    },
                    {
                        "ref-fulltext": "Dretzke J, Edlin R, Round J, et al. A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-Î±) inhibitors, adalimumab and infliximab, for Crohn\u2019s disease. Health Technol Assess. 2011; 15: 1\u2013244.",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-Î±) inhibitors, adalimumab and infliximab, for Crohn\u2019s disease"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0016",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "79951639158",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "15"},
                                "pagerange": {
                                    "@first": "1",
                                    "@last": "244"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Dretzke",
                                        "ce:indexed-name": "Dretzke J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Edlin",
                                        "ce:indexed-name": "Edlin R."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Round",
                                        "ce:indexed-name": "Round J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Health Technol Assess"
                        },
                        "ce:source-text": "Dretzke J, Edlin R, Round J, et al. A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-Î±) inhibitors, adalimumab and infliximab, for Crohn\u2019s disease. Health Technol Assess. 2011; 15: 1\u2013244."
                    },
                    {
                        "ref-fulltext": "Chaikledkaew U, Teerawattananon Y, editors; Thai Working Group on Health Technology Assessment Guidelines in Thailand. Thai health technology accessment guideline. 2 ed. Chulalongkorn University Book Center; 2013.",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0017",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85089441503",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "2 ed, Chulalongkorn University Book Center, editors",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "U.",
                                        "@_fa": "true",
                                        "ce:surname": "Chaikledkaew",
                                        "ce:indexed-name": "Chaikledkaew U."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Teerawattananon",
                                        "ce:indexed-name": "Teerawattananon Y."
                                    }
                                ],
                                "collaboration": {
                                    "@seq": "1",
                                    "ce:text": "Thai Working Group on Health Technology Assessment Guidelines in Thailand",
                                    "ce:indexed-name": "Thai Working Group on Health Technology Assessment Guidelines in Thailand"
                                }
                            },
                            "ref-sourcetitle": "Thai health technology accessment guideline"
                        },
                        "ce:source-text": "Chaikledkaew U, Teerawattananon Y, editors; Thai Working Group on Health Technology Assessment Guidelines in Thailand. Thai health technology accessment guideline. 2 ed. Chulalongkorn University Book Center; 2013."
                    },
                    {
                        "ref-fulltext": "Thai Working Group on Health Technology Assessment Guidelines in Thailand. Thai Health Technology Accessment Guideline. J Med Assoc Thai. 2008; 91: S1\u2013S88.",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Thai Health Technology Accessment Guideline"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0018",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84899631662",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "91"},
                                "pagerange": {
                                    "@first": "S1",
                                    "@last": "S88"
                                }
                            },
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "Thai Working Group on Health Technology Assessment Guidelines in Thailand",
                                "ce:indexed-name": "Thai Working Group on Health Technology Assessment Guidelines in Thailand"
                            }},
                            "ref-sourcetitle": "J Med Assoc Thai"
                        },
                        "ce:source-text": "Thai Working Group on Health Technology Assessment Guidelines in Thailand. Thai Health Technology Accessment Guideline. J Med Assoc Thai. 2008; 91: S1\u2013S88."
                    },
                    {
                        "ref-fulltext": "Gisbert JP, Marin AC, Chaparro M., The risk of relapse after anti-TNF discontinuation in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol. 2016; 111: 632\u2013647.",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "The risk of relapse after anti-TNF discontinuation in inflammatory bowel disease: systematic review and meta-analysis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0019",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84966658369",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "111"},
                                "pagerange": {
                                    "@first": "632",
                                    "@last": "647"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.P.",
                                    "@_fa": "true",
                                    "ce:surname": "Gisbert",
                                    "ce:indexed-name": "Gisbert J.P."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Marin",
                                    "ce:indexed-name": "Marin A.C."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Chaparro",
                                    "ce:indexed-name": "Chaparro M."
                                }
                            ]},
                            "ref-sourcetitle": "Am J Gastroenterol"
                        },
                        "ce:source-text": "Gisbert JP, Marin AC, Chaparro M., The risk of relapse after anti-TNF discontinuation in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol. 2016; 111: 632\u2013647."
                    },
                    {
                        "ref-fulltext": "Louis E, Mary JY, Vernier-Massouille G, et al.; Groupe D'etudes ThÃ©rapeutiques Des Affections Inflammatoires Digestives. Maintenance of remission among patients with Crohn\u2019s disease on antimetabolite therapy after infliximab therapy is stopped. Gastroenterology. 2012; 142: 63\u201370 e5; quiz e31.",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Maintenance of remission among patients with Crohn\u2019s disease on antimetabolite therapy after infliximab therapy is stopped"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0020",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "83955162272",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "142"},
                                "pagerange": {
                                    "@first": "63",
                                    "@last": "70 e5"
                                }
                            },
                            "ref-text": "quiz e31",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Louis",
                                        "ce:indexed-name": "Louis E."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Mary",
                                        "ce:indexed-name": "Mary J.Y."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Vernier-Massouille",
                                        "ce:indexed-name": "Vernier-Massouille G."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "Louis E, Mary JY, Vernier-Massouille G, et al.; Groupe D'etudes ThÃ©rapeutiques Des Affections Inflammatoires Digestives. Maintenance of remission among patients with Crohn\u2019s disease on antimetabolite therapy after infliximab therapy is stopped. Gastroenterology. 2012; 142: 63\u201370 e5; quiz e31."
                    },
                    {
                        "ref-fulltext": "Reenaers C, Mary JY, Nachury M, et al.; Groupe d'Etude Therapeutique des Affections Inflammatoires du tube Digestif. Outcomes 7 Years After Infliximab Withdrawal for Patients With Crohn\u2019s Disease in Sustained Remission. Clin Gastroenterol Hepatol. 2018; 16: 234\u2013243 e2.",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Outcomes 7 Years After Infliximab Withdrawal for Patients With Crohn\u2019s Disease in Sustained Remission"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0021",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85044712911",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "16"},
                                "pagerange": {
                                    "@first": "234",
                                    "@last": "243 e2"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Reenaers",
                                        "ce:indexed-name": "Reenaers C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Mary",
                                        "ce:indexed-name": "Mary J.Y."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Nachury",
                                        "ce:indexed-name": "Nachury M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Gastroenterol Hepatol"
                        },
                        "ce:source-text": "Reenaers C, Mary JY, Nachury M, et al.; Groupe d'Etude Therapeutique des Affections Inflammatoires du tube Digestif. Outcomes 7 Years After Infliximab Withdrawal for Patients With Crohn\u2019s Disease in Sustained Remission. Clin Gastroenterol Hepatol. 2018; 16: 234\u2013243 e2."
                    },
                    {
                        "ref-fulltext": "Bodger K, Kikuchi T, Hughes D., Cost-effectiveness of biological therapy for Crohn\u2019s disease: Markov cohort analyses incorporating United Kingdom patient-level cost data. Aliment Pharmacol Ther. 2009; 30: 265\u2013274.",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Cost-effectiveness of biological therapy for Crohn\u2019s disease: Markov cohort analyses incorporating United Kingdom patient-level cost data"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0022",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "67650439288",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "30"},
                                "pagerange": {
                                    "@first": "265",
                                    "@last": "274"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Bodger",
                                    "ce:indexed-name": "Bodger K."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Kikuchi",
                                    "ce:indexed-name": "Kikuchi T."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Hughes",
                                    "ce:indexed-name": "Hughes D."
                                }
                            ]},
                            "ref-sourcetitle": "Aliment Pharmacol Ther"
                        },
                        "ce:source-text": "Bodger K, Kikuchi T, Hughes D., Cost-effectiveness of biological therapy for Crohn\u2019s disease: Markov cohort analyses incorporating United Kingdom patient-level cost data. Aliment Pharmacol Ther. 2009; 30: 265\u2013274."
                    },
                    {
                        "ref-fulltext": "Rerknimitr R, Chalapipat O, Kongkam P, et al. Clinical characteristics of inflammatory bowel disease in Thailand: a 16 years review. J Med Assoc Thai. 2005; 88: S129\u2013S33.",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Clinical characteristics of inflammatory bowel disease in Thailand: a 16 years review"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0023",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "33646831337",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "88"},
                                "pagerange": {
                                    "@first": "S129",
                                    "@last": "S33"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Rerknimitr",
                                        "ce:indexed-name": "Rerknimitr R."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "O.",
                                        "@_fa": "true",
                                        "ce:surname": "Chalapipat",
                                        "ce:indexed-name": "Chalapipat O."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Kongkam",
                                        "ce:indexed-name": "Kongkam P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Med Assoc Thai"
                        },
                        "ce:source-text": "Rerknimitr R, Chalapipat O, Kongkam P, et al. Clinical characteristics of inflammatory bowel disease in Thailand: a 16 years review. J Med Assoc Thai. 2005; 88: S129\u2013S33."
                    },
                    {
                        "ref-fulltext": "Targan SR, Hanauer SB, van Deventer SJ, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn\u2019s disease. N Engl J Med. 1997; 337: 1029\u20131035.",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1997"},
                            "ref-title": {"ref-titletext": "A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn\u2019s disease"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0024",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0030954732",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "337"},
                                "pagerange": {
                                    "@first": "1029",
                                    "@last": "1035"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.R.",
                                        "@_fa": "true",
                                        "ce:surname": "Targan",
                                        "ce:indexed-name": "Targan S.R."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.B.",
                                        "@_fa": "true",
                                        "ce:surname": "Hanauer",
                                        "ce:indexed-name": "Hanauer S.B."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.J.",
                                        "@_fa": "true",
                                        "ce:surname": "van Deventer",
                                        "ce:indexed-name": "van Deventer S.J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Targan SR, Hanauer SB, van Deventer SJ, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn\u2019s disease. N Engl J Med. 1997; 337: 1029\u20131035."
                    },
                    {
                        "ref-fulltext": "Buhl S, Steenholdt C, Rasmussen M, et al. Outcomes after primary infliximab treatment failure in inflammatory bowel disease. Inflamm Bowel Dis. 2017; 23: 1210\u20131217.",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Outcomes after primary infliximab treatment failure in inflammatory bowel disease"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0025",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85021261709",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "23"},
                                "pagerange": {
                                    "@first": "1210",
                                    "@last": "1217"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Buhl",
                                        "ce:indexed-name": "Buhl S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Steenholdt",
                                        "ce:indexed-name": "Steenholdt C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Rasmussen",
                                        "ce:indexed-name": "Rasmussen M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Inflamm Bowel Dis"
                        },
                        "ce:source-text": "Buhl S, Steenholdt C, Rasmussen M, et al. Outcomes after primary infliximab treatment failure in inflammatory bowel disease. Inflamm Bowel Dis. 2017; 23: 1210\u20131217."
                    },
                    {
                        "ref-fulltext": "Hendler SA, Cohen BL, Colombel JF, et al. High-dose infliximab therapy in Crohn\u2019s disease: clinical experience, safety, and efficacy. J Crohns Colitis. 2015; 9: 266\u2013275.",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "High-dose infliximab therapy in Crohn\u2019s disease: clinical experience, safety, and efficacy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0026",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84942566280",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "9"},
                                "pagerange": {
                                    "@first": "266",
                                    "@last": "275"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Hendler",
                                        "ce:indexed-name": "Hendler S.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Cohen",
                                        "ce:indexed-name": "Cohen B.L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.F.",
                                        "@_fa": "true",
                                        "ce:surname": "Colombel",
                                        "ce:indexed-name": "Colombel J.F."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Crohns Colitis"
                        },
                        "ce:source-text": "Hendler SA, Cohen BL, Colombel JF, et al. High-dose infliximab therapy in Crohn\u2019s disease: clinical experience, safety, and efficacy. J Crohns Colitis. 2015; 9: 266\u2013275."
                    },
                    {
                        "ref-fulltext": "Silverstein MD, Loftus EV, Sandborn WJ, et al. Clinical course and costs of care for Crohn\u2019s disease: Markov model analysis of a population-based cohort. Gastroenterology. 1999; 117: 49\u201357.",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1999"},
                            "ref-title": {"ref-titletext": "Clinical course and costs of care for Crohn\u2019s disease: Markov model analysis of a population-based cohort"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0027",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0033022146",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "117"},
                                "pagerange": {
                                    "@first": "49",
                                    "@last": "57"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.D.",
                                        "@_fa": "true",
                                        "ce:surname": "Silverstein",
                                        "ce:indexed-name": "Silverstein M.D."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.V.",
                                        "@_fa": "true",
                                        "ce:surname": "Loftus",
                                        "ce:indexed-name": "Loftus E.V."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "W.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Sandborn",
                                        "ce:indexed-name": "Sandborn W.J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "Silverstein MD, Loftus EV, Sandborn WJ, et al. Clinical course and costs of care for Crohn\u2019s disease: Markov model analysis of a population-based cohort. Gastroenterology. 1999; 117: 49\u201357."
                    },
                    {
                        "ref-fulltext": "Mao EJ, Hazlewood GS, Kaplan GG, et al. Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn\u2019s disease and ulcerative colitis. Aliment Pharmacol Ther. 2017; 45: 3\u201313.",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn\u2019s disease and ulcerative colitis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0028",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85001967776",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "45"},
                                "pagerange": {
                                    "@first": "3",
                                    "@last": "13"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Mao",
                                        "ce:indexed-name": "Mao E.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Hazlewood",
                                        "ce:indexed-name": "Hazlewood G.S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Kaplan",
                                        "ce:indexed-name": "Kaplan G.G."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Aliment Pharmacol Ther"
                        },
                        "ce:source-text": "Mao EJ, Hazlewood GS, Kaplan GG, et al. Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn\u2019s disease and ulcerative colitis. Aliment Pharmacol Ther. 2017; 45: 3\u201313."
                    },
                    {
                        "ref-fulltext": "Hanauer SB, Feagan BG, Lichtenstein GR, et al. Maintenance infliximab for Crohn\u2019s disease: the ACCENT I randomised trial. Lancet. 2002; 359: 1541\u20131549.",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2002"},
                            "ref-title": {"ref-titletext": "Maintenance infliximab for Crohn\u2019s disease: the ACCENT I randomised trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0029",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0037018761",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "359"},
                                "pagerange": {
                                    "@first": "1541",
                                    "@last": "1549"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.B.",
                                        "@_fa": "true",
                                        "ce:surname": "Hanauer",
                                        "ce:indexed-name": "Hanauer S.B."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Feagan",
                                        "ce:indexed-name": "Feagan B.G."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G.R.",
                                        "@_fa": "true",
                                        "ce:surname": "Lichtenstein",
                                        "ce:indexed-name": "Lichtenstein G.R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Hanauer SB, Feagan BG, Lichtenstein GR, et al. Maintenance infliximab for Crohn\u2019s disease: the ACCENT I randomised trial. Lancet. 2002; 359: 1541\u20131549."
                    },
                    {
                        "ref-fulltext": "Life tables by country: Thailand. World Health organization; 2016 [2018 Oct 18]. Available from: http://apps.who.int/gho/data/view.main.61640?lang=en",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-website": {"ce:e-address": {
                                "$": "http://apps.who.int/gho/data/view.main.61640?lang=en",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0030",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85089449857",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "World Health organization;, 2018 Oct 18, Available from",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "Life tables by country: Thailand",
                                "ce:indexed-name": "Life tables by country: Thailand"
                            }}
                        },
                        "ce:source-text": "Life tables by country: Thailand. World Health organization; 2016 [2018 Oct 18]. Available from: http://apps.who.int/gho/data/view.main.61640?lang=en"
                    },
                    {
                        "ref-fulltext": "Lichtenstein GR, Feagan BG, Cohen RD, et al. Serious infection and mortality in patients with Crohn\u2019s disease: more than 5 years of follow-up in the TREAT registry. Am J Gastroenterol. 2012; 107: 1409\u20131422.",
                        "@id": "31",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Serious infection and mortality in patients with Crohn\u2019s disease: more than 5 years of follow-up in the TREAT registry"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0031",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84866122837",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "107"},
                                "pagerange": {
                                    "@first": "1409",
                                    "@last": "1422"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "G.R.",
                                        "@_fa": "true",
                                        "ce:surname": "Lichtenstein",
                                        "ce:indexed-name": "Lichtenstein G.R."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Feagan",
                                        "ce:indexed-name": "Feagan B.G."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.D.",
                                        "@_fa": "true",
                                        "ce:surname": "Cohen",
                                        "ce:indexed-name": "Cohen R.D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Am J Gastroenterol"
                        },
                        "ce:source-text": "Lichtenstein GR, Feagan BG, Cohen RD, et al. Serious infection and mortality in patients with Crohn\u2019s disease: more than 5 years of follow-up in the TREAT registry. Am J Gastroenterol. 2012; 107: 1409\u20131422."
                    },
                    {
                        "ref-fulltext": "Riewpaiboon A., Standard cost lists for health technology assessment. Nonthaburi: Health Intervention and Technology Assessment Program (HITAP); 2011 [cited 2019 Feb 28]. Available from: http://costingmenu.hitap.net/",
                        "@id": "32",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-website": {"ce:e-address": {
                                "$": "http://costingmenu.hitap.net/",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0032",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85089449264",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "Standard cost lists for health technology assessment. Nonthaburi: Health Intervention and Technology Assessment Program (HITAP);, [cited 2019 Feb 28]. Available from",
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "A.",
                                "@_fa": "true",
                                "ce:surname": "Riewpaiboon",
                                "ce:indexed-name": "Riewpaiboon A."
                            }]}
                        },
                        "ce:source-text": "Riewpaiboon A., Standard cost lists for health technology assessment. Nonthaburi: Health Intervention and Technology Assessment Program (HITAP); 2011 [cited 2019 Feb 28]. Available from: http://costingmenu.hitap.net/"
                    },
                    {
                        "ref-fulltext": "Riewpaiboon A., Measurement of costs. J Med Assoc Thai. 2008; 91: S28\u2013S37.",
                        "@id": "33",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Measurement of costs"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0033",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "62449273257",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "91"},
                                "pagerange": {
                                    "@first": "S28",
                                    "@last": "S37"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "A.",
                                "@_fa": "true",
                                "ce:surname": "Riewpaiboon",
                                "ce:indexed-name": "Riewpaiboon A."
                            }]},
                            "ref-sourcetitle": "J Med Assoc Thai"
                        },
                        "ce:source-text": "Riewpaiboon A., Measurement of costs. J Med Assoc Thai. 2008; 91: S28\u2013S37."
                    },
                    {
                        "ref-fulltext": "Historical Foreign Exchange Rates [Internet]. Bank of Thailand; 2017 [cited 2019 Aug 1]. Available from: https://www.bot.or.th",
                        "@id": "34",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.bot.or.th",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0034",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85089443980",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "[Internet]. Bank of Thailand;, [cited 2019 Aug 1]. Available from",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "Historical Foreign Exchange Rates",
                                "ce:indexed-name": "Historical Foreign Exchange Rates"
                            }}
                        },
                        "ce:source-text": "Historical Foreign Exchange Rates [Internet]. Bank of Thailand; 2017 [cited 2019 Aug 1]. Available from: https://www.bot.or.th"
                    },
                    {
                        "ref-fulltext": "Consumer Price index (CPI) of Thailand, Economic and Trade Indices Database (ETID) [Internet]. Bureau of Trade and Economic Indices, Ministry of Commerce; 2017 [cited 2019 May 16]. Available from: http://www.price.moc.go.th",
                        "@id": "35",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "http://www.price.moc.go.th",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0035",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85089448143",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "Consumer Price index (CPI) of Thailand, Economic and Trade Indices Database (ETID) [Internet]. Bureau of Trade and Economic Indices, Ministry of Commerce; 2017 [cited, May 16]. Available from"
                        },
                        "ce:source-text": "Consumer Price index (CPI) of Thailand, Economic and Trade Indices Database (ETID) [Internet]. Bureau of Trade and Economic Indices, Ministry of Commerce; 2017 [cited 2019 May 16]. Available from: http://www.price.moc.go.th"
                    },
                    {
                        "ref-fulltext": "Pattanaphesaj J., Health-related quality of life measure (EQ-5D-5L): measurement property testing and its preference-based score in Thai population [dissertation]. Mahidol University; 2014.",
                        "@id": "36",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0036",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85089444849",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "Health-related quality of life measure (EQ-5D-5L): measurement property testing and its preference-based score Thai population [dissertation]. Mahidol University",
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "J.",
                                "@_fa": "true",
                                "ce:surname": "Pattanaphesaj",
                                "ce:indexed-name": "Pattanaphesaj J."
                            }]}
                        },
                        "ce:source-text": "Pattanaphesaj J., Health-related quality of life measure (EQ-5D-5L): measurement property testing and its preference-based score in Thai population [dissertation]. Mahidol University; 2014."
                    },
                    {
                        "ref-fulltext": "Briggs A, Sculpher M, Claxton K., Decision modelling for health economic evaluation. Oxford: OUP; 2006.",
                        "@id": "37",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0037",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "33750600521",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "Oxford: OUP",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Briggs",
                                    "ce:indexed-name": "Briggs A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Sculpher",
                                    "ce:indexed-name": "Sculpher M."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Claxton",
                                    "ce:indexed-name": "Claxton K."
                                }
                            ]},
                            "ref-sourcetitle": "Decision modelling for health economic evaluation"
                        },
                        "ce:source-text": "Briggs A, Sculpher M, Claxton K., Decision modelling for health economic evaluation. Oxford: OUP; 2006."
                    },
                    {
                        "ref-fulltext": "Limwattananon S., Handling uncertainty of the economic evaluation result: sensitivity analysis. J Med Assoc Thai. 2008; 91 Suppl 2: S59\u2013S65.",
                        "@id": "38",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Handling uncertainty of the economic evaluation result: sensitivity analysis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0038",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "62449178267",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "91 Suppl 2"},
                                "pagerange": {
                                    "@first": "S59",
                                    "@last": "S65"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "ce:surname": "Limwattananon",
                                "ce:indexed-name": "Limwattananon S."
                            }]},
                            "ref-sourcetitle": "J Med Assoc Thai"
                        },
                        "ce:source-text": "Limwattananon S., Handling uncertainty of the economic evaluation result: sensitivity analysis. J Med Assoc Thai. 2008; 91 Suppl 2: S59\u2013S65."
                    },
                    {
                        "ref-fulltext": "Saito S, Shimizu U, Nan Z, et al. A health economic analysis of combination therapy with infliximab plus elemental diet for moderately to severely active Crohn\u2019s disease. Health. 2014; 06: 107\u2013114.",
                        "@id": "39",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "A health economic analysis of combination therapy with infliximab plus elemental diet for moderately to severely active Crohn\u2019s disease"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0039",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84909959277",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "6"},
                                "pagerange": {
                                    "@first": "107",
                                    "@last": "114"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Saito",
                                        "ce:indexed-name": "Saito S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "U.",
                                        "@_fa": "true",
                                        "ce:surname": "Shimizu",
                                        "ce:indexed-name": "Shimizu U."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Z.",
                                        "@_fa": "true",
                                        "ce:surname": "Nan",
                                        "ce:indexed-name": "Nan Z."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Health"
                        },
                        "ce:source-text": "Saito S, Shimizu U, Nan Z, et al. A health economic analysis of combination therapy with infliximab plus elemental diet for moderately to severely active Crohn\u2019s disease. Health. 2014; 06: 107\u2013114."
                    },
                    {
                        "ref-fulltext": "Vasudevan A, Gibson PR, Van Langenberg DR., Systematic review: cost-effective strategies of optimizing anti-tumor necrosis and immunomodulators in inflammatory bowel disease. Inflamm Bowel Dis. 2019; 25: 1462\u20131473.",
                        "@id": "40",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Systematic review: cost-effective strategies of optimizing anti-tumor necrosis and immunomodulators in inflammatory bowel disease"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0040",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85067668116",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "25"},
                                "pagerange": {
                                    "@first": "1462",
                                    "@last": "1473"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Vasudevan",
                                    "ce:indexed-name": "Vasudevan A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "P.R.",
                                    "@_fa": "true",
                                    "ce:surname": "Gibson",
                                    "ce:indexed-name": "Gibson P.R."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "D.R.",
                                    "@_fa": "true",
                                    "ce:surname": "Van Langenberg",
                                    "ce:indexed-name": "Van Langenberg D.R."
                                }
                            ]},
                            "ref-sourcetitle": "Inflamm Bowel Dis"
                        },
                        "ce:source-text": "Vasudevan A, Gibson PR, Van Langenberg DR., Systematic review: cost-effective strategies of optimizing anti-tumor necrosis and immunomodulators in inflammatory bowel disease. Inflamm Bowel Dis. 2019; 25: 1462\u20131473."
                    },
                    {
                        "ref-fulltext": "Rencz F, Gulacsi L, Pentek M, et al. Cost-utility of biological treatment sequences for luminal Crohn\u2019s disease in Europe. Expert Rev Pharmacoecon Outcomes Res. 2017; 17: 597\u2013606.",
                        "@id": "41",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Cost-utility of biological treatment sequences for luminal Crohn\u2019s disease in Europe"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0041",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85018171573",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "17"},
                                "pagerange": {
                                    "@first": "597",
                                    "@last": "606"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Rencz",
                                        "ce:indexed-name": "Rencz F."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Gulacsi",
                                        "ce:indexed-name": "Gulacsi L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Pentek",
                                        "ce:indexed-name": "Pentek M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Expert Rev Pharmacoecon Outcomes Res"
                        },
                        "ce:source-text": "Rencz F, Gulacsi L, Pentek M, et al. Cost-utility of biological treatment sequences for luminal Crohn\u2019s disease in Europe. Expert Rev Pharmacoecon Outcomes Res. 2017; 17: 597\u2013606."
                    },
                    {
                        "ref-fulltext": "Vasudevan A, Ip F, Liew D, et al. The Cost-effectiveness of initial immunomodulators or infliximab using modern optimization strategies for Crohn\u2019s disease in the biosimilar era. Inflamm Bowel Dis. 2020; 26: 369\u2013379.",
                        "@id": "42",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "The Cost-effectiveness of initial immunomodulators or infliximab using modern optimization strategies for Crohn\u2019s disease in the biosimilar era"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0042",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85079326015",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "26"},
                                "pagerange": {
                                    "@first": "369",
                                    "@last": "379"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Vasudevan",
                                        "ce:indexed-name": "Vasudevan A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Ip",
                                        "ce:indexed-name": "Ip F."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Liew",
                                        "ce:indexed-name": "Liew D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Inflamm Bowel Dis"
                        },
                        "ce:source-text": "Vasudevan A, Ip F, Liew D, et al. The Cost-effectiveness of initial immunomodulators or infliximab using modern optimization strategies for Crohn\u2019s disease in the biosimilar era. Inflamm Bowel Dis. 2020; 26: 369\u2013379."
                    },
                    {
                        "ref-fulltext": "Drummond M, Barbieri M, Cook J, et al., editors. Transferability of economic evaluations across jurisdictions. International Society for Pharmacoeconomic and Outcomes Research (ISPOR)\u201313th International Meeting; 2008.",
                        "@id": "43",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0043",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85089452577",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "editors. Transferability of economic evaluations across jurisdictions. International Society for Pharmacoeconomic and Outcomes Research (ISPOR13th International Meeting",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Drummond",
                                        "ce:indexed-name": "Drummond M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Barbieri",
                                        "ce:indexed-name": "Barbieri M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Cook",
                                        "ce:indexed-name": "Cook J."
                                    }
                                ],
                                "et-al": null
                            }
                        },
                        "ce:source-text": "Drummond M, Barbieri M, Cook J, et al., editors. Transferability of economic evaluations across jurisdictions. International Society for Pharmacoeconomic and Outcomes Research (ISPOR)\u201313th International Meeting; 2008."
                    },
                    {
                        "ref-fulltext": "Health intervention and technology assessment in support of universal health coverage. Ninth plenary meeting. Sixty-Seventh World Health Assembly; 2014 May 24.",
                        "@id": "44",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Health intervention and technology assessment in support of universal health coverage"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CIT0044",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85089447151",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "Sixty-Seventh World Health Assembly, May 24",
                            "ref-sourcetitle": "Ninth Plenary Meeting"
                        },
                        "ce:source-text": "Health intervention and technology assessment in support of universal health coverage. Ninth plenary meeting. Sixty-Seventh World Health Assembly; 2014 May 24."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60011189",
            "affilname": "Faculty of Medicine Siriraj Hospital, Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011189",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199578",
            "affilname": "Ramathibodi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Salt Lake City",
            "@id": "60025488",
            "affilname": "The University of Utah",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025488",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60020543",
            "affilname": "Bumrungrad International Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020543",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60015887",
            "affilname": "Faculty of Medicine Ramathibodi Hospital, Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015887",
            "affiliation-country": "Thailand"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85089453513",
        "dc:description": "Aims: This study aimed to conduct a cost-effectiveness analysis of infliximab and its biosimilar compared to conventional therapy in refractory moderate-to-severe Crohn\u2019s disease (CD) in Thailand. Materials and methods: A Markov model was used to estimate lifetime costs and health benefits of infliximab from a societal perspective. Our analyses consisted of three choices of treatment (conventional therapy, infliximab originator, and biosimilar) and three treatment scenarios (infliximab 2 years and 3 years if relapse, infliximab 2 years and lifelong if relapse, and infliximab lifelong). The input parameters were obtained from the CD registry and systematic literature reviews. The results were reported as incremental cost-effectiveness ratios (ICERs) in 2017 USD per quality-adjusted life year (QALY) gained. The sensitivity analyses were performed to assess the influence of parameter uncertainty. Threshold sensitivity analyses were carried out to determine the optimal drug prices. Finally, budget impact analyses were conducted. Results: None of the scenarios was cost-effective at Thai willingness-to-pay threshold (4,706 USD/QALY gained). The lowest ICER of 30,121 USD/QALY gained was reported in the scenario that included only standard dose of infliximab biosimilar with the maximum of 5-year treatment. The drug prices need to be reduced by at least 72% to allow infliximab biosimilar to be cost-effective. The 5-year budget impact was only 695,958 USD for the current biosimilar price. Conclusions: Infliximab for the treatment of refractory moderate-to-severe CD in Thailand would be cost-effective if the drug prices were significantly decreased. The best value for money strategy was infliximab biosimilar with a restricted duration of treatment.Key points The use of infliximab and its biosimilar in a restricted duration of maximum 5-year is not cost-effective for patients with moderate-to-severe Crohn\u2019s disease refractory to conventional therapy, unless their price was lowered around 72\u201390% in Thailand. The estimated budget impact for adopting infliximab or its biosimilar for such indication has potential financial feasibility. Policy makers may consider cost-effectiveness and budget impact findings as well as other aspects such as rarity of disease as a part of the decision making process.",
        "pubmed-id": "32729347",
        "prism:coverDate": "2020-11-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85089453513",
        "dc:creator": {"author": [{
            "ce:given-name": "Pochamana",
            "preferred-name": {
                "ce:given-name": "Pochamana",
                "ce:initials": "P.",
                "ce:surname": "Phisalprapa",
                "ce:indexed-name": "Phisalprapa P."
            },
            "@seq": "1",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60011189",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011189"
            },
            "ce:surname": "Phisalprapa",
            "@auid": "54419010300",
            "author-url": "https://api.elsevier.com/content/author/author_id/54419010300",
            "ce:indexed-name": "Phisalprapa P."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85089453513"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85089453513&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85089453513&origin=inward"
            }
        ],
        "source-id": "15951",
        "citedby-count": "2",
        "prism:volume": "23",
        "subtype": "ar",
        "dc:title": "Cost-effectiveness and budget impact analysis of infliximab and its biosimilar in patients with refractory moderate-to-severe Crohn\u2019s disease using real world evidence in Thailand",
        "openaccess": "1",
        "prism:issn": "1941837X 13696998",
        "publishercopyright": "Â© 2020 Informa UK Limited, trading as Taylor & Francis Group.",
        "prism:issueIdentifier": "11",
        "subtypeDescription": "Article",
        "prism:publicationName": "Journal of Medical Economics",
        "prism:pageRange": "1302-1310",
        "prism:endingPage": "1310",
        "openaccessFlag": "true",
        "prism:doi": "10.1080/13696998.2020.1803889",
        "prism:startingPage": "1302",
        "dc:identifier": "SCOPUS_ID:85089453513",
        "dc:publisher": "Taylor and Francis Ltd."
    },
    "idxterms": {"mainterm": [
        {
            "$": "Biosimilar Pharmaceuticals",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Budgets",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Cost-Benefit Analysis",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Crohn Disease",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Health Expenditures",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Infliximab",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Models, Economic",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Quality-Adjusted Life Years",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Recurrence",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Severity of Illness Index",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Thailand",
            "@weight": "b",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "biosimilar"
        },
        {
            "@_fa": "true",
            "$": "Cost-effectiveness analysis"
        },
        {
            "@_fa": "true",
            "$": "Crohn's disease"
        },
        {
            "@_fa": "true",
            "$": "infliximab"
        },
        {
            "@_fa": "true",
            "$": "Thailand"
        }
    ]},
    "subject-areas": {"subject-area": [{
        "@_fa": "true",
        "$": "Health Policy",
        "@code": "2719",
        "@abbrev": "MEDI"
    }]},
    "authors": {"author": [
        {
            "ce:given-name": "Pochamana",
            "preferred-name": {
                "ce:given-name": "Pochamana",
                "ce:initials": "P.",
                "ce:surname": "Phisalprapa",
                "ce:indexed-name": "Phisalprapa P."
            },
            "@seq": "1",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60011189",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011189"
            },
            "ce:surname": "Phisalprapa",
            "@auid": "54419010300",
            "author-url": "https://api.elsevier.com/content/author/author_id/54419010300",
            "ce:indexed-name": "Phisalprapa P."
        },
        {
            "ce:given-name": "Chayanis",
            "preferred-name": {
                "ce:given-name": "Chayanis",
                "ce:initials": "C.",
                "ce:surname": "Kositamongkol",
                "ce:indexed-name": "Kositamongkol C."
            },
            "@seq": "2",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60011189",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011189"
            },
            "ce:surname": "Kositamongkol",
            "@auid": "57218533231",
            "author-url": "https://api.elsevier.com/content/author/author_id/57218533231",
            "ce:indexed-name": "Kositamongkol C."
        },
        {
            "ce:given-name": "Julajak",
            "preferred-name": {
                "ce:given-name": "Julajak",
                "ce:initials": "J.",
                "ce:surname": "Limsrivilai",
                "ce:indexed-name": "Limsrivilai J."
            },
            "@seq": "3",
            "ce:initials": "J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60011189",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011189"
            },
            "ce:surname": "Limsrivilai",
            "@auid": "12772292800",
            "author-url": "https://api.elsevier.com/content/author/author_id/12772292800",
            "ce:indexed-name": "Limsrivilai J."
        },
        {
            "ce:given-name": "Satimai",
            "preferred-name": {
                "ce:given-name": "Satimai",
                "ce:initials": "S.",
                "ce:surname": "Aniwan",
                "ce:indexed-name": "Aniwan S."
            },
            "@seq": "4",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Aniwan",
            "@auid": "36010544000",
            "author-url": "https://api.elsevier.com/content/author/author_id/36010544000",
            "ce:indexed-name": "Aniwan S."
        },
        {
            "ce:given-name": "Phunchai",
            "preferred-name": {
                "ce:given-name": "Phunchai",
                "ce:initials": "P.",
                "ce:surname": "Charatcharoenwitthaya",
                "ce:indexed-name": "Charatcharoenwitthaya P."
            },
            "@seq": "5",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60011189",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011189"
            },
            "ce:surname": "Charatcharoenwitthaya",
            "@auid": "12778111900",
            "author-url": "https://api.elsevier.com/content/author/author_id/12778111900",
            "ce:indexed-name": "Charatcharoenwitthaya P."
        },
        {
            "ce:given-name": "Pises",
            "preferred-name": {
                "ce:given-name": "Pises",
                "ce:initials": "P.",
                "ce:surname": "Pisespongsa",
                "ce:indexed-name": "Pisespongsa P."
            },
            "@seq": "6",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60020543",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020543"
            },
            "ce:surname": "Pisespongsa",
            "@auid": "15846592300",
            "author-url": "https://api.elsevier.com/content/author/author_id/15846592300",
            "ce:indexed-name": "Pisespongsa P."
        },
        {
            "ce:given-name": "Taya",
            "preferred-name": {
                "ce:given-name": "Taya",
                "ce:initials": "T.",
                "ce:surname": "Kitiyakara",
                "ce:indexed-name": "Kitiyakara T."
            },
            "@seq": "7",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60199578",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578"
            },
            "ce:surname": "Kitiyakara",
            "@auid": "8275586600",
            "author-url": "https://api.elsevier.com/content/author/author_id/8275586600",
            "ce:indexed-name": "Kitiyakara T."
        },
        {
            "ce:given-name": "Suporn",
            "preferred-name": {
                "ce:given-name": "Suporn",
                "ce:initials": "S.",
                "ce:surname": "Treepongkaruna",
                "ce:indexed-name": "Treepongkaruna S."
            },
            "@seq": "8",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60015887",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015887"
            },
            "ce:surname": "Treepongkaruna",
            "@auid": "57195461878",
            "author-url": "https://api.elsevier.com/content/author/author_id/57195461878",
            "ce:indexed-name": "Treepongkaruna S."
        },
        {
            "ce:given-name": "Nathorn",
            "preferred-name": {
                "ce:given-name": "Nathorn",
                "ce:initials": "N.",
                "ce:surname": "Chaiyakunapruk",
                "ce:indexed-name": "Chaiyakunapruk N."
            },
            "@seq": "9",
            "ce:initials": "N.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60025488",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025488"
            },
            "ce:surname": "Chaiyakunapruk",
            "@auid": "14015058100",
            "author-url": "https://api.elsevier.com/content/author/author_id/14015058100",
            "ce:indexed-name": "Chaiyakunapruk N."
        }
    ]}
}}